North American (NA) subgroup results from VELOUR: Ziv-aflibercept versus placebo plus FOLFIRI in mCRC that is resistant to or has progressed after an oxaliplatin-containing regimen.
Edith P. Mitchell
Honoraria - Sanofi
Research Funding - Genentech
Michael J. Guarino
No relevant relationships to disclose
Michael L. Andria
Employment or Leadership Position - Regeneron
Pankaj Bhargava
Employment or Leadership Position - Sanofi
Stock Ownership - Sanofi
Jeffrey J. Kirshner
No relevant relationships to disclose